Hjeltnes, Gunnbjørg <br/><br/>
Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors.  [electronic resource] 

 -  The Journal of rheumatology  Jul 2012 
 - 1341-7 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1499-2752 
<br/><br/><label>Standard No.: </label>10.3899/jrheum.111401  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>Cardiovascular Diseases--blood<br/>Cartilage Oligomeric Matrix Protein<br/>Drug Therapy, Combination<br/>Endothelium, Vascular--drug effects<br/>Extracellular Matrix Proteins--blood<br/>Female<br/>Glucocorticoids--therapeutic use<br/>Glycoproteins--blood<br/>Humans<br/>Hyperemia--blood<br/>Male<br/>Matrilin Proteins<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Risk Factors<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors